Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

Vaccine

Volumn 16, Issue 11-12, 1998, Pages 1131-1137

  Heath, David G ^a   Anderson Jr , George W ^a   Mauro, J Matthew ^b   Welkos, Susan L ^a   Andrews, Gerard P ^a   Adamovicz, Jeffrey ^a   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

Author keywords

Plague; Recombinant vaccine; Yersinia pestis

Indexed keywords

PLAGUE VACCINE; RECOMBINANT CAPSULAR F1 V ANTIGEN FUSION PROTEIN VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; YERSINIA PESTIS;

EID: 0031750789     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)80110-2     Document Type: Article

References (35)

1. Centers for Disease Control. Update: Human Plague - India. MMWR, 1994, 43, 722-733
2. Meyer, K.F. Effectiveness of live or killed plague vaccines in man. Bull. WHO 1970, 42, 653-666.
3. Pitt, M.L.M., Estep, E.J., Welkos, S.L. and Friedlander, A. Efficacy of killed whole-cell vaccine against a lethal aerosol challenge of plague in rodents, In: Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, DC
4. Speck, R.S. and Wolchow, H. Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. J. Infect. Dis. 1957, 100, 58-69.
5. Cavanaugh, D.C., Elisberg, B.L., Llewellyn, C.H., Marshall, J.D., Rust, J.H., Williams, J.E. and Meyer, K.F. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J. Infect. Dis. 1974, 129, S37-40.
6. Burrows, T.W. Virulence of Pasteurella pestis. Nature 1957, 179, 1246-1247.
7. Williams, J.E. and Cavanaugh, D.C. Measuring the efficacy of vaccination in affording protection against plague. Bull. WHO 1979, 57, 309-313.
8. Protsenko, O.A., Anisimov, P.I., Mozharov, O.T., Konnov, N.P., Popov, Yu.A. and Kokushkin, A.M. Detection and characterization of Yersinia pestis plasmids determining pesticin I, Fraction I antigen, and "Mouse" toxin synthesis. Genetika 1983, 19, 1081-1090.
9. Welkos, S.L., Davis, K.M., Pitt, L.M., Worsham, P.L. and Friedlander, A.M. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 1995, 13, 299-305.
10. Winter, C.C., Cherry, W.B. and Moody, M.D. An unusual strain of Pasturella pestis isolated from a fatal human case of plague. Bull. WHO 1960, 23, 408-409.
11. Drozdov, I.G., Anisimov, A.P., Samoilova, S.V., Yezhov, I.N., Yeremin, S.A., Karlyshev, V.M. and Kravchenko, V.I. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J. Med. Microbiol. 1995, 42, 264-268.
12. Worsham, P.L., Stein, M-P. and Welkos, S.L. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib. Microbiol. Immunol. 1995, 13, 325-328.
13. Friedlander, A.M., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, G.W. Jr., Pitt, M.L.M., Estep, J. and Davis, K. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 1995, 21 (suppl 2), S178-181.
14. Straley, S.C., Skrzypek, E., Plano, G.V. and Bliska, J.B. Yops of Yersinia spp. pathogenic for humans. Infect. Immun. 1993, 61, 3105-3110.
15. Sodeinde, O.A. and Goguen, J. Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis. Infect. Immun. 1988, 56, 2743-2748.
16. Baker, E.E., Sommer, H., Foster, L.E., Meyer, E. and Meyer, K.F. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J. Immunol. 1952, 68, 131-145.
17. Burrows, T.W. Virulence of Pasteurella pestis and immunity to plague. Ergeb. Mikrobiol. Immunitatsforch. Exp. Ther. 1963, 37, 59-113.
18. Simpson, W.J., Thomas, R.E. and Schwan, T.G. Recombinant capsular antigen (Fraction 1) from Yersinia pestis induces a protective antibody response in Balb/C mice. Am. J. Trop. Med. Hyg. 1990, 43, 389-396.
19. Andrews, G.P., Heath, D.G., Anderson, G.W. Jr.Jr., Welkos, S.L. and Friedlander, A.M. Fraction 1 Capsular Antigen (F1) purification from Yersinia pestis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 1996, 64, 2180-2187.
20. Bergman, T., Hakansson, S., Forsberg, A., Norlander, L., Macellaro, A., Backman, A., Bolin, I. and Wolf-Watz, H. Analysis of the V antigen IcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV. J. Bacteriol. 1991, 173, 1607-1616.
21. 2+ response virulence genes. J. Bacteriol. 1991, 173, 2649-2657.
22. Nakajima, R., Motin, V.L. and Brubaker, R.R. Suppression of cytokines in mice by Protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 1995, 63, 3021-3029.
23. Lawton, W.D., Erdman, R.L. and Surgalla, M.J. Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immunol. 1963, 91, 179-184.
24. Motin, V.L., Nakajima, R., Smirnov, G.B. and Brubaker, R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 1994, 62, 4192-4201.
25. Sato, K., Nakajima, R., Hara, F., Une, T. and Osada, Y. Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib. Microbiol. Immunol. 1991, 12, 225-229.
26. Leary, S.E.C., Williamson, E.D., Griffin, K.F., Russell, P., Eley, S.M. and Titball, R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 1995, 63, 2854-2858.
27. Motin, V.L., Nedialkov, Y.A. and Brubaker, R.R. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect. Immun. 1996, 64, 4313-4318.
28. Heath, D.G., Anderson, G.W., Jr., Welkos, S.L., Andrews, G.P., Friedlander, A.M. and Mauro, J.M. A recombinant capsular F1-V antigen fusion protein vaccine protects against experimental bubonic and pneumonic plague, In Vaccines 97 (Eds Brown, F., Burton, D., Doherty, P., Mekalanos, J. and Norrby, E.). Cold Spring Harbor Laboratory Press, NY, 1997, pp. 197-200
29. Sanger, F., Nicklen, S. and Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977, 74, 5463-5467.
30. Sambrook, J., Fritsch, E.F. and Maniatis, T. (eds) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989
31. Price, S.B., Leung, K.Y., Barve, S.S. and Straley, S.C. Molecular analysis of IcrGVH, the V antigen operon of Yersinia pestis. J. Bacteriol. 1989, 171, 5646-5653.
32. Anderson, G.W. Jr., Leary, S.E.C., Williamson, E.D., Titball, R.W., Welkos, S.L., Worsham, P.L. and Friedlander, A.M. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 1996, 64, 4580-4585.
33. SAS version 6.10, SAS Institute, Cary, NC, 1994
34. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Resources, National Research Council. Guidelines for the Care and Use of Laboratory Animals, Revised. National Institutes of Health Publication no. 86-23. National Institutes of Health, Bethesda, MD, 1985
35. Smith, H. and Packman, L.P. A filtered non-toxic plague vaccine protects guinea-pigs and mice. Brit. J. Exp. Path. 1966, 47, 25-34.